554 related articles for article (PubMed ID: 33390772)
1. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
2. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
[TBL] [Abstract][Full Text] [Related]
3. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.
Shen Z; Zeng Y; Guo J; Wu Y; Jiang X; Ding R; Wu C; Li R; Luo B; Zeng C; Jiang H; Jie W
J Transl Med; 2013 Sep; 11():217. PubMed ID: 24047082
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin combined with metformin inhibits migration and invasion of human nasopharyngeal carcinoma cells by regulating E-cadherin and MMP-9.
Sun XJ; Zhang P; Li HH; Jiang ZW; Jiang CC; Liu H
Asian Pac J Cancer Prev; 2014; 15(9):4019-23. PubMed ID: 24935589
[TBL] [Abstract][Full Text] [Related]
5. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
Deng YF; Zhou DN; Pan ZY; Yin P
Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
[TBL] [Abstract][Full Text] [Related]
6. MiR-30e-5p inhibits proliferation and metastasis of nasopharyngeal carcinoma cells by target-ing USP22.
Ma YX; Zhang H; Li XH; Liu YH
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6342-6349. PubMed ID: 30338802
[TBL] [Abstract][Full Text] [Related]
7. Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma.
Ye CS; Zhou DN; Yang QQ; Deng YF
Int J Clin Exp Pathol; 2014; 7(3):914-22. PubMed ID: 24696710
[TBL] [Abstract][Full Text] [Related]
8. Targeting FoxM1 inhibits proliferation, invasion and migration of nasopharyngeal carcinoma through the epithelial‑to-mesenchymal transition pathway.
Yu C; Chen L; Yie L; Wei L; Wen T; Liu Y; Chen H
Oncol Rep; 2015 May; 33(5):2402-10. PubMed ID: 25738652
[TBL] [Abstract][Full Text] [Related]
9. NEDD4 is involved in acquisition of epithelial-mesenchymal transition in cisplatin-resistant nasopharyngeal carcinoma cells.
Feng S; Yang G; Yang H; Liang Z; Zhang R; Fan Y; Zhang G
Cell Cycle; 2017 May; 16(9):869-878. PubMed ID: 28379054
[TBL] [Abstract][Full Text] [Related]
10. MiR-122-5p suppresses cell proliferation, migration and invasion by targeting SATB1 in nasopharyngeal carcinoma.
Liu YH; Liu JL; Wang Z; Zhu XH; Chen XB; Wang MQ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):622-629. PubMed ID: 30720170
[TBL] [Abstract][Full Text] [Related]
11. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo.
Shi J; Tan S; Song L; Song L; Wang Y
Biomed Pharmacother; 2020 Jan; 121():109620. PubMed ID: 31810117
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of long non-coding RNA TUG1 suppresses nasopharyngeal carcinoma progression by inhibiting epithelial-mesenchymal transition (EMT) via the promotion of miR-384.
Qian W; Ren Z; Lu X
Biochem Biophys Res Commun; 2019 Jan; 509(1):56-63. PubMed ID: 30581000
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
Wu Q; Han T; Sheng X; Zhang N; Wang P
Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
[TBL] [Abstract][Full Text] [Related]
14. [Effects of enhancer of zeste homolog (EZH2) downregulation on the proliferation and invasion of nasopharyngeal carcinoma cell and the possible mechanisms].
LIANG BJ; LI XP; LU J; LIN SX; LIU X; LI G; ZHANG B; WANG L; LUO HN; WAN RQ; TIAN WD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):298-304. PubMed ID: 22800347
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-296-5p inhibits cell metastasis and invasion in nasopharyngeal carcinoma by reversing transforming growth factor-β-induced epithelial-mesenchymal transition.
Chen M; Chen C; Luo H; Ren J; Dai Q; Hu W; Zhou K; Tang X; Li X
Cell Mol Biol Lett; 2020 Nov; 25(1):49. PubMed ID: 33292168
[TBL] [Abstract][Full Text] [Related]
16. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
17. MALAT1/miR-124/Capn4 axis regulates proliferation, invasion and EMT in nasopharyngeal carcinoma cells.
Shi B; Wang Y; Yin F
Cancer Biol Ther; 2017 Oct; 18(10):792-800. PubMed ID: 28857668
[TBL] [Abstract][Full Text] [Related]
18. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
[TBL] [Abstract][Full Text] [Related]
19. MircoRNA-629 promotes proliferation, invasion and migration of nasopharyngeal carcinoma through targeting PDCD4.
Zheng YQ; Bai YF; Yang S; Cui YR; Wang YP; Hu WL
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):207-216. PubMed ID: 30657562
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-577/EIF5A2 axis suppressed the proliferation of DDP-resistant nasopharyngeal carcinoma cells by blocking TGF-β signaling pathway.
Wu R; Zhong Q; Liu H; Liu S
Chem Biol Drug Des; 2023 Oct; 102(4):815-827. PubMed ID: 37500510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
